Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

ViroPharma, Inc. (NASDAQ:VPHM.DL)

CAPS Rating: No stars

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VPHM.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

yesand (< 20)
Submitted July 29, 2011

Good pharma in pipeline

rmbashir (< 20)
Submitted September 26, 2006

NO SOLID PHASE 3 TRIALS.HAVE MANY FAILURES IN THE PIPELINE; ALOT OF COMPETETION FOR HEP C, INCLUDING INGENIX AND SCHERING WITH PROTEASE INHIBITORS COMING OUT. NEED NEW BLOOD COARSING THROUGH ITS VEINS OR COULD SETTLE IN AT 11-13.

NASDAQ:VPHM.DL VS S&P 500 (SPY)

NASDAQ:VPHM.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about VPHM.DL.

No one has written a Pitch for VPHM.DL stock yet. Tell us why you think VPHM.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in VPHM.DL.

No players have picked VPHM.DL yet. Tell us why you think VPHM.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VPHM.DL.